跳至主要内容
临床试验/CTRI/2025/02/080927
CTRI/2025/02/080927尚未招募4 期

A Clinical Study on Menorrhagia in Reproductive Age Group with its Homoeopathic Approach

R.B.T.S Govt. Homoeopathic Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年2月25日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
The response of the patient will be assessed by a scoring system at base line after a prescribed homoeopathic medicine on the basis of individualisation and acts curatively in case of menorrhagia with no side effects

研究概览

简要总结

Menorrhagia is classified as abnormal uterine bleeding, characterized by regular menstrual cycles with excessive blood flow (greater than 80 ml) or prolonged duration (over 7 days) or both. Certain regions, such as Bihar, experience even higher rates of occurrence. This condition not only affects the quality of life but also poses significant physical and emotional health risks to women. At the RBTS Government Homoeopathic Medical College & Hospital OPD, a large number of patients present regularly with menorrhagia, seeking alternative treatments. Given the growing interest in homeopathic approaches to managing gynecological conditions, a study on menorrhagia with a focus on homeopathic treatment holds great promise. RBTS Government Homoeopathic Medical College & Hospital, with its large patient base and well-equipped facilities, provides an ideal platform for conducting such research. This study will explore the effectiveness of homeopathic remedies in managing menorrhagia, contributing valuable insights into alternative therapeutic approaches for this widespread condition.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • •patients of age 18 years to 45 years of reproductive age group.
  • •Heavy menstrual bleeding for three months or longer.
  • •Patients willing to give consent to participate in the study.
  • •Hemoglobin more than 7mg/dl.

排除标准

  • •Patients with any gross pathology.
  • •Patients with the history of any chronic disease or comorbidity.
  • •Patients who will not agree to participate in study.
  • •Hemoglobin less than 7 mg/dl.
  • •Pregnant and lactating women.
  • •Patients who had taken OCP pills for last 6 weeks.
  • •Patient taking any other treatment for menorrhagia from other system of medicine.

结局指标

主要结局

The response of the patient will be assessed by a scoring system at base line after a prescribed homoeopathic medicine on the basis of individualisation and acts curatively in case of menorrhagia with no side effects

时间窗: 3 months

次要结局

  • The response of the patient will be assessed through presence of symptoms, clinical observation and quality of life of patient at base line

研究者

发起方
R.B.T.S Govt. Homoeopathic Medical College and Hospital
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Rita Kumari

R.B.T.S Govt. Homoeopathic Medical College and Hospital Muzaffarpur Bihar

研究点 (1)

Loading locations...

相似试验